盈科瑞（横琴）药物研究院

Yingkerui (Hengqin) Drug Research Institute is a specialized pharmaceutical R&D organization and CRO located in the Guangdong-Macao In-Depth Cooperation Zone. As a key subsidiary of Beijing Yingkerui Pharmaceutical Technology, it focuses on the modernization of Traditional Chinese Medicine (TCM) through innovative drug delivery systems (DDS). The institute's core expertise lies in developing nebulized inhalation preparations, skin-targeted delivery systems, and ophthalmic drugs. It offers comprehensive services including drug discovery, formulation optimization, and clinical registration support to both domestic and international partners. The facility serves as a strategic bridge for TCM internationalization, leveraging its advanced laboratories and pilot-scale production capabilities to advance herbal-based therapies into modern clinical applications.